SCHEMBL17477015

SCHEMBL17477015

COc1ccc(-c2nc3c(c(N4CCc5ccc(OCC(=O)N(C)C)cc54)n2)CS(=O)(=O)C3)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4B Q07343 2/20 0.39
▸ MTOR P42345 6/20 0.38
▸ PIK3CA P42336 3/20 0.38
▸ POLB P06746 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ALDH1A1 P00352 2/20 0.35
▸ LMNA P02545 1/20 0.35
▸ HTT P42858 1/20 0.35
▸ TSHR P16473 2/20 0.34
▸ CYP3A4 P08684 1/20 0.34
▸ CYP2C9 P11712 1/20 0.34
▸ CYP2C19 P33261 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ HDAC3 O15379 1/20 0.33
▸ HDAC4 P56524 1/20 0.33
▸ HDAC1 Q13547 1/20 0.33
▸ HDAC7 Q8WUI4 1/20 0.33
▸ HDAC2 Q92769 1/20 0.33
▸ HDAC10 Q969S8 1/20 0.33
▸ HDAC11 Q96DB2 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17477018 0.92 RAB9A (0.39) MTORPOLBRAB9AALDH1A1TSHR
SCHEMBL17477017 0.92 PDE4B (0.39) PDE4BMTORPIK3CAPOLBALDH1A1
SCHEMBL17476958 0.91 POLB (0.34) PDE4BMTORPIK3CAPOLBRAB9A
SCHEMBL17477025 0.90 PDE4B (0.44) PDE4BMTORPIK3CA
SCHEMBL17476893 0.90 S1PR1 (0.36) PDE4BMTORPIK3CAALDH1A1LMNA
SCHEMBL17476983 0.90 PDE4B (0.35) PDE4BMTORPIK3CAPOLBALDH1A1
SCHEMBL16179402 0.88 PDE4B (0.38) PDE4BALDH1A1LMNAHTTCYP3A4
SCHEMBL16179480 0.86 RAB9A (0.37) PDE4BPOLBRAB9AALDH1A1KDM4E
SCHEMBL17477005 0.85 PDE4B (0.40) PDE4BMTORPIK3CAPOLBRAB9A
SCHEMBL17476949 0.85 ALDH1A1 (0.33) PDE4BMTORPIK3CAPOLBALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2986600-B1 SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS GRUENENTHAL GMBH (DE) 2017-07-05 — — EP disclosed
US-9527832-B2 Substituted condensed pyrimidine compounds Grünenthal GmbH (DE) 2016-12-27 — — US disclosed
US-20160031857-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-02-04 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160031857-A1 NOVEL SUBSTITUTED CONDENSED PYRIMIDINE COMPOUNDS TYMP, PDE4A, DPYD PDE4B 4/4885MTOR 3569/4885PIK3CA 868/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback